Portal de Periódicos da CAPES

Successfully treated severe COVID‐19 and invasive aspergillosis in early hematopoietic cell transplantation setting

2020; Wiley; Volume: 23; Issue: 2 Linguagem: Inglês

10.1111/tid.13470

1399-3062

Manuela Spadea, Francesca Carraro, Francesco Saglio, Elena Vassallo, Rosanna Pessolano, Massimo Berger, Carlo Scolfaro, Sergio Grassitelli, Franca Fagioli,

Neutropenia and Cancer Infections

Transplant Infectious DiseaseVolume 23, Issue 2 e13470 LETTER TO THE EDITOR Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting Manuela Spadea, Corresponding Author Manuela Spadea [email protected] orcid.org/0000-0001-7728-904X Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy Correspondence Manuela Spadea, MD, Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Piazza Polonia 94 - 10126 Torino, Italy. Email: [email protected]Search for more papers by this authorFrancesca Carraro, Francesca Carraro Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorFrancesco Saglio, Francesco Saglio orcid.org/0000-0002-1795-0446 Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorElena Vassallo, Elena Vassallo Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorRosanna Pessolano, Rosanna Pessolano Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorMassimo Berger, Massimo Berger orcid.org/0000-0003-3455-3802 Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorCarlo Scolfaro, Carlo Scolfaro Pediatric Infectious Disease Unit, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorSergio Grassitelli, Sergio Grassitelli Pediatric Intensive Care Unit, Regina Margherita Children's Hospital, Turin, ItalySearch for more papers by this authorFranca Fagioli, Franca Fagioli orcid.org/0000-0002-9257-900X Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this author Manuela Spadea, Corresponding Author Manuela Spadea [email protected] orcid.org/0000-0001-7728-904X Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy Correspondence Manuela Spadea, MD, Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Piazza Polonia 94 - 10126 Torino, Italy. Email: [email protected]Search for more papers by this authorFrancesca Carraro, Francesca Carraro Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorFrancesco Saglio, Francesco Saglio orcid.org/0000-0002-1795-0446 Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorElena Vassallo, Elena Vassallo Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorRosanna Pessolano, Rosanna Pessolano Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorMassimo Berger, Massimo Berger orcid.org/0000-0003-3455-3802 Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorCarlo Scolfaro, Carlo Scolfaro Pediatric Infectious Disease Unit, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this authorSergio Grassitelli, Sergio Grassitelli Pediatric Intensive Care Unit, Regina Margherita Children's Hospital, Turin, ItalySearch for more papers by this authorFranca Fagioli, Franca Fagioli orcid.org/0000-0002-9257-900X Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, ItalySearch for more papers by this author First published: 22 September 2020 https://doi.org/10.1111/tid.13470Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C. Clin Infect Dis. 2008; 46(12): 1813-1821. https://doi.org/10.1086/588660 10.1086/588660 PubMedWeb of Science®Google Scholar 2Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-A groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013; 31(22): 2810-2818. https://doi.org/10.1200/JCO.2012.47.2365 10.1200/JCO.2012.47.2365 PubMedWeb of Science®Google Scholar 3Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949 10.1016/j.ijantimicag.2020.105949 CASPubMedWeb of Science®Google Scholar 4Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5): 1094-1099. https://doi.org/10.1111/jth.14817 10.1111/jth.14817 CASPubMedWeb of Science®Google Scholar 5Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020; 382(24): 2327-2336. https://doi.org/10.1056/nejmoa2007016 10.1056/NEJMoa2007016 CASPubMedWeb of Science®Google Scholar 6Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — preliminary report. N Engl J Med. 2020; 383(10): 994. https://doi.org/10.1056/NEJMoa2007764 PubMedWeb of Science®Google Scholar 7Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006; 3(9):e343. https://doi.org/10.1371/journal.pmed.0030343 10.1371/journal.pmed.0030343 CASPubMedWeb of Science®Google Scholar 8Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 2018; 197(6): 757-767. https://doi.org/10.1164/rccm.201706-1172OC 10.1164/rccm.201706-1172OC PubMedWeb of Science®Google Scholar 9Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. An official American Thoracic Society Research Statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011; 183(9): 1262-1279. https://doi.org/10.1164/rccm.2007-413ST 10.1164/rccm.2007-413ST PubMedWeb of Science®Google Scholar 10Malavolta M, Giacconi R, Brunetti D, Provinciali M, Maggi F. Exploring the relevance of senotherapeutics for the current SARS-CoV-2 emergency and similar future global health threats. Cells. 2020; 9(4):909. https://doi.org/10.3390/cells9040909 10.3390/cells9040909 CASPubMedWeb of Science®Google Scholar 11Jin XH, Zheng KI, Pan KH, Xie YP, Zheng MH. COVID-19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020; 7(4): e351-e352. https://doi.org/10.1016/S2352-3026(20)30074-0 10.1016/S2352-3026(20)30074-0 PubMedWeb of Science®Google Scholar 12Huang J, Lin H, Wu Y, et al. COVID-19 in posttransplant patients—report of 2 cases. Am J Transplant. 2020; 20(7): 1879-1881. https://doi.org/10.1111/ajt.15896 10.1111/ajt.15896 CASPubMedWeb of Science®Google Scholar 13Cao Y, Wei J, Zou L, et al. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020; 146(1): 137–146.e3. https://doi.org/10.1016/j.jaci.2020.05.019 10.1016/j.jaci.2020.05.019 CASPubMedWeb of Science®Google Scholar Citing Literature Volume23, Issue2April 2021e13470 ReferencesRelatedInformation